Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/10/18 | S-3 | Registration statement for specified transactions by certain issuers |
|
26 | |
| 05/18/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/16/18 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
6 | |
| 05/15/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
43 |
| 05/14/18 | 8-K | Current report filing |
|
12 | |
| 05/11/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/11/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/08/18 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
33 | |
| 05/08/18 | 8-K/A | Current report filing |
|
85 | |
| 05/08/18 | 8-K | Current report filing |
|
84 |
